nodes	percent_of_prediction	percent_of_DWPC	metapath
Sotalol—ADRB1—dilated cardiomyopathy	0.443	0.543	CbGaD
Sotalol—ADRB2—dilated cardiomyopathy	0.373	0.457	CbGaD
Sotalol—KCNH2—purkinje fiber—dilated cardiomyopathy	0.045	0.546	CbGeAlD
Sotalol—KCNH2—endocardium—dilated cardiomyopathy	0.0232	0.281	CbGeAlD
Sotalol—Sustained ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.0128	0.147	CcSEcCtD
Sotalol—ADRB1—cardiac ventricle—dilated cardiomyopathy	0.00255	0.031	CbGeAlD
Sotalol—ADRB1—myocardium—dilated cardiomyopathy	0.0024	0.0292	CbGeAlD
Sotalol—KCNH2—cardiac ventricle—dilated cardiomyopathy	0.00195	0.0237	CbGeAlD
Sotalol—KCNH2—myocardium—dilated cardiomyopathy	0.00184	0.0223	CbGeAlD
Sotalol—ADRB1—heart—dilated cardiomyopathy	0.00168	0.0204	CbGeAlD
Sotalol—Lethargy—Spironolactone—dilated cardiomyopathy	0.00167	0.0192	CcSEcCtD
Sotalol—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.00165	0.0189	CcSEcCtD
Sotalol—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00148	0.0169	CcSEcCtD
Sotalol—ADRB1—cardiac atrium—dilated cardiomyopathy	0.00143	0.0174	CbGeAlD
Sotalol—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.0014	0.0161	CcSEcCtD
Sotalol—Heartburn—Lisinopril—dilated cardiomyopathy	0.00134	0.0154	CcSEcCtD
Sotalol—KCNH2—heart—dilated cardiomyopathy	0.00128	0.0155	CbGeAlD
Sotalol—Hyperlipidaemia—Lisinopril—dilated cardiomyopathy	0.00128	0.0147	CcSEcCtD
Sotalol—Throat sore—Lisinopril—dilated cardiomyopathy	0.00128	0.0147	CcSEcCtD
Sotalol—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.00127	0.0145	CcSEcCtD
Sotalol—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00126	0.0145	CcSEcCtD
Sotalol—Orciprenaline—ADRB2—dilated cardiomyopathy	0.00124	0.181	CrCbGaD
Sotalol—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.0012	0.0138	CcSEcCtD
Sotalol—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00118	0.0135	CcSEcCtD
Sotalol—Practolol—ADRB1—dilated cardiomyopathy	0.00112	0.163	CrCbGaD
Sotalol—Lightheadedness—Furosemide—dilated cardiomyopathy	0.0011	0.0126	CcSEcCtD
Sotalol—KCNH2—cardiac atrium—dilated cardiomyopathy	0.0011	0.0133	CbGeAlD
Sotalol—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00102	0.0117	CcSEcCtD
Sotalol—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.00101	0.0116	CcSEcCtD
Sotalol—Alopecia—Spironolactone—dilated cardiomyopathy	0.001	0.0115	CcSEcCtD
Sotalol—Vascular purpura—Furosemide—dilated cardiomyopathy	0.000997	0.0114	CcSEcCtD
Sotalol—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000949	0.0109	CcSEcCtD
Sotalol—Purpura—Furosemide—dilated cardiomyopathy	0.000926	0.0106	CcSEcCtD
Sotalol—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.000922	0.0106	CcSEcCtD
Sotalol—Lethargy—Furosemide—dilated cardiomyopathy	0.00091	0.0104	CcSEcCtD
Sotalol—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000884	0.0101	CcSEcCtD
Sotalol—Photophobia—Lisinopril—dilated cardiomyopathy	0.000866	0.00993	CcSEcCtD
Sotalol—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.000825	0.00946	CcSEcCtD
Sotalol—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.000821	0.00941	CcSEcCtD
Sotalol—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000803	0.00921	CcSEcCtD
Sotalol—Esmolol—ADRB1—dilated cardiomyopathy	0.000802	0.117	CrCbGaD
Sotalol—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000789	0.00905	CcSEcCtD
Sotalol—Abdominal distension—Furosemide—dilated cardiomyopathy	0.000776	0.0089	CcSEcCtD
Sotalol—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.000773	0.00887	CcSEcCtD
Sotalol—Eosinophilia—Furosemide—dilated cardiomyopathy	0.000763	0.00876	CcSEcCtD
Sotalol—Somnolence—Spironolactone—dilated cardiomyopathy	0.000716	0.00822	CcSEcCtD
Sotalol—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000704	0.00807	CcSEcCtD
Sotalol—Atenolol—ADRB1—dilated cardiomyopathy	0.0007	0.102	CrCbGaD
Sotalol—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000696	0.00798	CcSEcCtD
Sotalol—ADRB2—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.000691	0.0883	CbGpPWpGaD
Sotalol—Drowsiness—Furosemide—dilated cardiomyopathy	0.000688	0.00788	CcSEcCtD
Sotalol—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.000683	0.00783	CcSEcCtD
Sotalol—Esmolol—ADRB2—dilated cardiomyopathy	0.000674	0.0986	CrCbGaD
Sotalol—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.000669	0.00768	CcSEcCtD
Sotalol—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000642	0.00736	CcSEcCtD
Sotalol—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000637	0.00731	CcSEcCtD
Sotalol—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000603	0.00691	CcSEcCtD
Sotalol—Visual impairment—Furosemide—dilated cardiomyopathy	0.000595	0.00682	CcSEcCtD
Sotalol—Atenolol—ADRB2—dilated cardiomyopathy	0.000588	0.0861	CrCbGaD
Sotalol—Influenza—Lisinopril—dilated cardiomyopathy	0.000579	0.00663	CcSEcCtD
Sotalol—Asthma—Lisinopril—dilated cardiomyopathy	0.000579	0.00663	CcSEcCtD
Sotalol—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000573	0.00657	CcSEcCtD
Sotalol—ADRB1—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.000572	0.0732	CbGpPWpGaD
Sotalol—Pruritus—Spironolactone—dilated cardiomyopathy	0.00057	0.00654	CcSEcCtD
Sotalol—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000569	0.00653	CcSEcCtD
Sotalol—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000564	0.00646	CcSEcCtD
Sotalol—Angiopathy—Furosemide—dilated cardiomyopathy	0.00056	0.00642	CcSEcCtD
Sotalol—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000551	0.00632	CcSEcCtD
Sotalol—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000551	0.00632	CcSEcCtD
Sotalol—Metoprolol—ADRB1—dilated cardiomyopathy	0.000545	0.0797	CrCbGaD
Sotalol—KCNH2—Hematopoietic Stem Cell Differentiation—CSF3—dilated cardiomyopathy	0.000539	0.0689	CbGpPWpGaD
Sotalol—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000538	0.00617	CcSEcCtD
Sotalol—Dizziness—Spironolactone—dilated cardiomyopathy	0.000533	0.00611	CcSEcCtD
Sotalol—Flatulence—Furosemide—dilated cardiomyopathy	0.000529	0.00607	CcSEcCtD
Sotalol—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000528	0.00606	CcSEcCtD
Sotalol—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000526	0.00603	CcSEcCtD
Sotalol—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000522	0.00598	CcSEcCtD
Sotalol—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000517	0.00592	CcSEcCtD
Sotalol—Depression—Lisinopril—dilated cardiomyopathy	0.000514	0.0059	CcSEcCtD
Sotalol—Vomiting—Spironolactone—dilated cardiomyopathy	0.000512	0.00588	CcSEcCtD
Sotalol—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000509	0.00583	CcSEcCtD
Sotalol—Rash—Spironolactone—dilated cardiomyopathy	0.000508	0.00583	CcSEcCtD
Sotalol—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000508	0.00582	CcSEcCtD
Sotalol—Vision blurred—Furosemide—dilated cardiomyopathy	0.000506	0.00581	CcSEcCtD
Sotalol—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000506	0.0058	CcSEcCtD
Sotalol—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000506	0.0058	CcSEcCtD
Sotalol—Headache—Spironolactone—dilated cardiomyopathy	0.000505	0.00579	CcSEcCtD
Sotalol—Vertigo—Furosemide—dilated cardiomyopathy	0.000483	0.00554	CcSEcCtD
Sotalol—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000481	0.00552	CcSEcCtD
Sotalol—Leukopenia—Furosemide—dilated cardiomyopathy	0.000481	0.00552	CcSEcCtD
Sotalol—Nausea—Spironolactone—dilated cardiomyopathy	0.000479	0.00549	CcSEcCtD
Sotalol—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000471	0.00541	CcSEcCtD
Sotalol—Metoprolol—ADRB2—dilated cardiomyopathy	0.000458	0.0671	CrCbGaD
Sotalol—Shock—Furosemide—dilated cardiomyopathy	0.000431	0.00495	CcSEcCtD
Sotalol—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000429	0.00492	CcSEcCtD
Sotalol—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000424	0.00486	CcSEcCtD
Sotalol—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00042	0.00482	CcSEcCtD
Sotalol—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000414	0.00474	CcSEcCtD
Sotalol—Hypotension—Furosemide—dilated cardiomyopathy	0.00041	0.0047	CcSEcCtD
Sotalol—Alopecia—Lisinopril—dilated cardiomyopathy	0.000409	0.00469	CcSEcCtD
Sotalol—Flatulence—Lisinopril—dilated cardiomyopathy	0.000397	0.00456	CcSEcCtD
Sotalol—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000395	0.00453	CcSEcCtD
Sotalol—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000394	0.00452	CcSEcCtD
Sotalol—Back pain—Lisinopril—dilated cardiomyopathy	0.00039	0.00447	CcSEcCtD
Sotalol—Somnolence—Furosemide—dilated cardiomyopathy	0.00039	0.00447	CcSEcCtD
Sotalol—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000388	0.00444	CcSEcCtD
Sotalol—Isoprenaline—ADRB1—dilated cardiomyopathy	0.000387	0.0566	CrCbGaD
Sotalol—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000381	0.00437	CcSEcCtD
Sotalol—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00038	0.00436	CcSEcCtD
Sotalol—Fatigue—Furosemide—dilated cardiomyopathy	0.000378	0.00434	CcSEcCtD
Sotalol—Pain—Furosemide—dilated cardiomyopathy	0.000375	0.0043	CcSEcCtD
Sotalol—Vertigo—Lisinopril—dilated cardiomyopathy	0.000362	0.00415	CcSEcCtD
Sotalol—Syncope—Lisinopril—dilated cardiomyopathy	0.000362	0.00415	CcSEcCtD
Sotalol—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000361	0.00414	CcSEcCtD
Sotalol—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000359	0.00411	CcSEcCtD
Sotalol—Palpitations—Lisinopril—dilated cardiomyopathy	0.000356	0.00409	CcSEcCtD
Sotalol—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000354	0.00406	CcSEcCtD
Sotalol—Cough—Lisinopril—dilated cardiomyopathy	0.000352	0.00403	CcSEcCtD
Sotalol—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000347	0.00398	CcSEcCtD
Sotalol—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000347	0.00398	CcSEcCtD
Sotalol—Chest pain—Lisinopril—dilated cardiomyopathy	0.000343	0.00394	CcSEcCtD
Sotalol—Myalgia—Lisinopril—dilated cardiomyopathy	0.000343	0.00394	CcSEcCtD
Sotalol—Anxiety—Lisinopril—dilated cardiomyopathy	0.000342	0.00392	CcSEcCtD
Sotalol—Oedema—Lisinopril—dilated cardiomyopathy	0.000329	0.00377	CcSEcCtD
Sotalol—Infection—Lisinopril—dilated cardiomyopathy	0.000327	0.00375	CcSEcCtD
Sotalol—KCNH2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000326	0.0417	CbGpPWpGaD
Sotalol—Isoprenaline—ADRB2—dilated cardiomyopathy	0.000325	0.0476	CrCbGaD
Sotalol—Shock—Lisinopril—dilated cardiomyopathy	0.000324	0.00371	CcSEcCtD
Sotalol—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000322	0.00369	CcSEcCtD
Sotalol—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000318	0.00365	CcSEcCtD
Sotalol—Asthenia—Furosemide—dilated cardiomyopathy	0.000315	0.00361	CcSEcCtD
Sotalol—Pruritus—Furosemide—dilated cardiomyopathy	0.00031	0.00356	CcSEcCtD
Sotalol—Hypotension—Lisinopril—dilated cardiomyopathy	0.000307	0.00353	CcSEcCtD
Sotalol—KCNH2—Potassium Channels—ABCC9—dilated cardiomyopathy	0.000302	0.0387	CbGpPWpGaD
Sotalol—Diarrhoea—Furosemide—dilated cardiomyopathy	0.0003	0.00344	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.0003	0.00344	CcSEcCtD
Sotalol—Insomnia—Lisinopril—dilated cardiomyopathy	0.000298	0.00341	CcSEcCtD
Sotalol—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000295	0.00339	CcSEcCtD
Sotalol—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000293	0.00336	CcSEcCtD
Sotalol—Somnolence—Lisinopril—dilated cardiomyopathy	0.000292	0.00335	CcSEcCtD
Sotalol—Dizziness—Furosemide—dilated cardiomyopathy	0.00029	0.00333	CcSEcCtD
Sotalol—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00029	0.00332	CcSEcCtD
Sotalol—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000286	0.00328	CcSEcCtD
Sotalol—Fatigue—Lisinopril—dilated cardiomyopathy	0.000284	0.00325	CcSEcCtD
Sotalol—Pain—Lisinopril—dilated cardiomyopathy	0.000281	0.00323	CcSEcCtD
Sotalol—Vomiting—Furosemide—dilated cardiomyopathy	0.000279	0.0032	CcSEcCtD
Sotalol—Rash—Furosemide—dilated cardiomyopathy	0.000276	0.00317	CcSEcCtD
Sotalol—Dermatitis—Furosemide—dilated cardiomyopathy	0.000276	0.00317	CcSEcCtD
Sotalol—Headache—Furosemide—dilated cardiomyopathy	0.000275	0.00315	CcSEcCtD
Sotalol—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000269	0.00309	CcSEcCtD
Sotalol—Nausea—Furosemide—dilated cardiomyopathy	0.00026	0.00299	CcSEcCtD
Sotalol—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00026	0.00298	CcSEcCtD
Sotalol—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00026	0.00298	CcSEcCtD
Sotalol—ADRB2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.000244	0.0312	CbGpPWpGaD
Sotalol—Asthenia—Lisinopril—dilated cardiomyopathy	0.000236	0.00271	CcSEcCtD
Sotalol—Pruritus—Lisinopril—dilated cardiomyopathy	0.000233	0.00267	CcSEcCtD
Sotalol—KCNH2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000232	0.0297	CbGpPWpGaD
Sotalol—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000225	0.00258	CcSEcCtD
Sotalol—Dizziness—Lisinopril—dilated cardiomyopathy	0.000218	0.00249	CcSEcCtD
Sotalol—Vomiting—Lisinopril—dilated cardiomyopathy	0.000209	0.0024	CcSEcCtD
Sotalol—Rash—Lisinopril—dilated cardiomyopathy	0.000207	0.00238	CcSEcCtD
Sotalol—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000207	0.00238	CcSEcCtD
Sotalol—Headache—Lisinopril—dilated cardiomyopathy	0.000206	0.00236	CcSEcCtD
Sotalol—ADRB2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000205	0.0263	CbGpPWpGaD
Sotalol—ADRB1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000202	0.0259	CbGpPWpGaD
Sotalol—ADRB2—Arf6 signaling events—AGTR1—dilated cardiomyopathy	0.000199	0.0254	CbGpPWpGaD
Sotalol—Nausea—Lisinopril—dilated cardiomyopathy	0.000195	0.00224	CcSEcCtD
Sotalol—ADRB1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00017	0.0217	CbGpPWpGaD
Sotalol—ADRB1—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000158	0.0202	CbGpPWpGaD
Sotalol—ADRB2—Arf6 trafficking events—AGTR1—dilated cardiomyopathy	0.000157	0.0201	CbGpPWpGaD
Sotalol—ADRB2—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000155	0.0198	CbGpPWpGaD
Sotalol—ADRB1—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000154	0.0197	CbGpPWpGaD
Sotalol—ADRB2—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00015	0.0192	CbGpPWpGaD
Sotalol—ADRB2—Arf6 trafficking events—ITGB1—dilated cardiomyopathy	0.000144	0.0184	CbGpPWpGaD
Sotalol—KCNH2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000132	0.0169	CbGpPWpGaD
Sotalol—ADRB1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000127	0.0163	CbGpPWpGaD
Sotalol—KCNH2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000127	0.0162	CbGpPWpGaD
Sotalol—ADRB2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000125	0.0159	CbGpPWpGaD
Sotalol—ADRB2—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.000112	0.0143	CbGpPWpGaD
Sotalol—ADRB1—Endothelin Pathways—RAF1—dilated cardiomyopathy	0.000104	0.0133	CbGpPWpGaD
Sotalol—KCNH2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	9.07e-05	0.0116	CbGpPWpGaD
Sotalol—ADRB2—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	8.47e-05	0.0108	CbGpPWpGaD
Sotalol—KCNH2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	7.87e-05	0.0101	CbGpPWpGaD
Sotalol—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	7.32e-05	0.00935	CbGpPWpGaD
Sotalol—ADRB1—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	7.02e-05	0.00897	CbGpPWpGaD
Sotalol—ADRB2—Arf6 signaling events—EGFR—dilated cardiomyopathy	6.67e-05	0.00852	CbGpPWpGaD
Sotalol—ADRB1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	6.17e-05	0.00789	CbGpPWpGaD
Sotalol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	6.06e-05	0.00775	CbGpPWpGaD
Sotalol—ADRB2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	6.04e-05	0.00772	CbGpPWpGaD
Sotalol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	5.35e-05	0.00684	CbGpPWpGaD
Sotalol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	5.24e-05	0.00669	CbGpPWpGaD
Sotalol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	4.98e-05	0.00636	CbGpPWpGaD
Sotalol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	4.87e-05	0.00622	CbGpPWpGaD
Sotalol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	4.72e-05	0.00603	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	4.59e-05	0.00586	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	4.59e-05	0.00586	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	4.49e-05	0.00574	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	4.49e-05	0.00574	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	4.26e-05	0.00545	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	4.17e-05	0.00533	CbGpPWpGaD
Sotalol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	4.12e-05	0.00526	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	4.04e-05	0.00516	CbGpPWpGaD
Sotalol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	4.03e-05	0.00515	CbGpPWpGaD
Sotalol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	3.91e-05	0.00499	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	3.53e-05	0.00451	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	3.49e-05	0.00447	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	3.49e-05	0.00447	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	3.45e-05	0.00441	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	3.42e-05	0.00437	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	3.42e-05	0.00437	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	3.35e-05	0.00428	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	3.25e-05	0.00415	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	3.18e-05	0.00406	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	3.08e-05	0.00393	CbGpPWpGaD
Sotalol—KCNH2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	2.99e-05	0.00383	CbGpPWpGaD
Sotalol—KCNH2—Neuronal System—RAF1—dilated cardiomyopathy	2.88e-05	0.00368	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	2.69e-05	0.00343	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	2.63e-05	0.00336	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	2.55e-05	0.00326	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	2.48e-05	0.00317	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	2.43e-05	0.0031	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	1.97e-05	0.00252	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	1.97e-05	0.00252	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	1.93e-05	0.00247	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	1.93e-05	0.00247	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—AGT—dilated cardiomyopathy	1.89e-05	0.00242	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—AGT—dilated cardiomyopathy	1.85e-05	0.00236	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	1.84e-05	0.00235	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	1.8e-05	0.00229	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	1.79e-05	0.00229	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	1.79e-05	0.00229	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	1.75e-05	0.00224	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	1.75e-05	0.00224	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	1.74e-05	0.00222	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	1.67e-05	0.00213	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	1.63e-05	0.00208	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	1.58e-05	0.00202	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.52e-05	0.00194	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.48e-05	0.0019	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	1.44e-05	0.00184	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.38e-05	0.00176	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.35e-05	0.00172	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.31e-05	0.00167	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.19e-05	0.00152	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.17e-05	0.00149	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.12e-05	0.00143	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.09e-05	0.0014	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.07e-05	0.00137	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.06e-05	0.00135	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.06e-05	0.00135	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.04e-05	0.00134	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.04e-05	0.00132	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.04e-05	0.00132	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.02e-05	0.0013	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	9.93e-06	0.00127	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.85e-06	0.00126	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	9.7e-06	0.00124	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.63e-06	0.00123	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	9.49e-06	0.00121	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.33e-06	0.00119	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.14e-06	0.00104	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.97e-06	0.00102	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.73e-06	0.000987	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.73e-06	0.000861	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.64e-06	0.000849	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.59e-06	0.000842	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.49e-06	0.00083	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	6e-06	0.000767	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	5.87e-06	0.00075	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	5.73e-06	0.000732	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	5.61e-06	0.000717	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.62e-06	0.00059	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.52e-06	0.000577	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	3.98e-06	0.000508	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	3.89e-06	0.000497	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.73e-06	0.000349	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	2.67e-06	0.000341	CbGpPWpGaD
